0001062993-23-003847.txt : 20230216 0001062993-23-003847.hdr.sgml : 20230216 20230216183200 ACCESSION NUMBER: 0001062993-23-003847 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230214 FILED AS OF DATE: 20230216 DATE AS OF CHANGE: 20230216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RANDLE STUART A CENTRAL INDEX KEY: 0001256144 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41403 FILM NUMBER: 23639793 MAIL ADDRESS: STREET 1: 585 WEST 500 SOUTH CITY: BOUNTIFUL STATE: UT ZIP: 84010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Comera Life Sciences Holdings, Inc. CENTRAL INDEX KEY: 0001907685 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 874706968 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12 GILL STREET STREET 2: SUITE 4650 CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: (617)871-2101 MAIL ADDRESS: STREET 1: 12 GILL STREET STREET 2: SUITE 4650 CITY: WOBURN STATE: MA ZIP: 01801 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2023-02-14 0001907685 Comera Life Sciences Holdings, Inc. CMRA 0001256144 RANDLE STUART A C/O COMERA LIFE SCIENCES HOLDINGS, INC. 12 GILL STREET, SUITE 4650 WOBURN MA 01801 1 0 0 0 Stock Option (Right to Purchase) 1.30 2023-02-14 4 A 0 7100 0 A 2033-02-14 Common Stock 7100 7100 D The stock option vests in 12 equal monthly installments beginning on March 14, 2023 such that the option will be fully vested on February 14, 2024, subject to continuous service to the issuer through each vesting date. /s/ Ryan M. Rourke Reed, Attorney-in-Fact 2023-02-16